Patient responsiveness to calcitonin salmon nasal spray: a subanalysis of a 2-year study

Clinical Therapeutics

Volumn 17, Issue 4, 1995, Pages 680-685

  Overgaard, Kirsten ^a   Lindsay, Robert ^b   Christiansen, Claus ^a  

^a CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

^b HELEN HAYES HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; NOSE SPRAY; PLACEBO; SALCATONIN;

AGED; ARTICLE; BONE DENSITY; BONE MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; HEADACHE; HUMAN; LUMBAR VERTEBRA; NAUSEA; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VERTIGO; X RAY ANALYSIS;

ABSORPTIOMETRY, PHOTON; ADMINISTRATION, INTRANASAL; AGED; BONE DENSITY; CALCITONIN; DOUBLE-BLIND METHOD; FEMALE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; PATIENT COMPLIANCE;

EID: 0029162604     PISSN: 01492918     EISSN: None     Source Type: Journal    
DOI: 10.1016/0149-2918(95)80044-1     Document Type: Article

References (17)

1. Diagnosis prophylaxis and treatment of osteoporosis
2. Prevention and treatment of osteoporosis
3. Calcitonin treatment in osteoporosis
4. Estimation of the effect of salmon calcitonin in established osteoporosis by biochemical bone markers
5. Effect of salmon calcitonin nasal spray on bone mass in patients with high turnover osteoporosis
6. Discontinuous calcitonin treatment of established osteoporosis—effects of withdrawal of treatment
7. Effect of intranasal salmon calcitonin therapy on bone mass and bone turnover in early postmenopausal women: A dose-response study
8. A 5-year controlled randomized study of prevention of postmenopausal trabecular bone loss with nasal salmon calcitonin and calcium
9. Effects of continuous and cyclic nasal calcitonin administration in ovariectomized women
10. An effective regimen of intranasal salmon calcitonin in early postmenopausal bone loss
11. Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin
12. Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: A dose-response study
13. Nasal calcitonin for treatment of established osteoporosis
14. Acute effects of calcitonin on osteoclasts in man
15. Effects of salmon calcitonin in postmenopausal osteoporosis: A controlled double-blind clinical study
16. Comparative effects on bone mineral content of calcium and calcium plus salmon calcitonin given in two different regimens in postmenopausal osteoporosis